[89Zr]Zr-DFO-TOC: a novel radiopharmaceutical for PET imaging of somatostatin receptor positive neuroendocrine tumors

[89Zr]Zr-DFO-TOC: a novel radiopharmaceutical for PET imaging of somatostatin receptor positive neuroendocrine tumors

Abstract Background Neuroendocrine tumors (NETs) are clinically diverse types of tumors that can arise anywhere in the body. Previous studies have shown that somatostatin receptors (SSTRs) are overexpressed on NET cell membranes relative to healthy tissue, allowing for tumor targeting through radiol...

Full description

Bibliographic Details
Main Authors: Alexis M. Sanwick, Katherine N. Haugh, Evan J. Williams, Kala A. Perry, Nikki A. Thiele, Ivis F. Chaple
Format: Article
Language:English
Published: SpringerOpen 2024-12-01
Series:EJNMMI Radiopharmacy and Chemistry
Subjects:
Radiopharmaceuticals
Somatostatin receptors
Octreotide
Neuroendocrine tumors
Positron emission tomography
Online Access:https://doi.org/10.1186/s41181-024-00320-9

Internet

https://doi.org/10.1186/s41181-024-00320-9

Similar Items